Original filing (PDF)20260708124114NAL0016342947001

Conjupro Biotherapeutics Inc.

Name: Conjupro Biotherapeutics Inc. — Conjupro Biotherapeu, Form 5500 (2025)
Creator: Conjupro Biotherapeutics Inc.
License: https://www.usa.gov/government-works

Form 5500-SF

FILING_RECEIVED

Conjupro Biotherapeutics Inc. 401(k) Plan

401(k) retirement plan · Conjupro Biotherapeutics Inc.'s Conjupro Biotherapeutics Inc. 401(k) Plan held $3.4M in plan assets for 15 participants in 2025.

Active participants

Accounts w/ balance

Plan assets (EOY)

$3.4M

Net assets (EOY)

$3.4M

Plan health score

Top-tier plan health

Directional indicator from public Form 5500 data — compliance & integrity, total plan cost, participant health and vendor stack, benchmarked against same-size peers. Not a fiduciary tool. Based on 70% of scoring inputs for this filing.

Compliance & integrity

100

Total plan cost

n/a

Plan health

Vendor & structure

100

Helping the score

Cost not scored — no comparable Schedule H expense data for this cohort.
High account-holder ratio — balance-holders per active participant in the top 15% of peers (90th percentile).

Decision-maker contacts

One unlock reveals every key decision-maker — plan signer, CFO, HR & Benefits — with verified email + LinkedIn for CONJUPRO BIOTHERAPEUTICS INC..

Plan sponsor

Name

CONJUPRO BIOTHERAPEUTICS INC.

EIN

46-0913476all filings

Address

302 CARNEGIE CENTER BLVD. SUITE 100 · PRINCETON, NJ · 08540

Phone

(609) 356-0210

Industry